HSF1 and breast cancer: In addition, hyperphosphorylation of serine 326, which is upregulated in breast cancer compared with its normal counterparts, has been used as a biomarker to indicate HSF1 activation in immortalized primary mammary epithelial tumor cells [53, 54].